News
03-28-2011, 08:21 AM
Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that enrollment has started for the Phase 1 clinical trial testing the safety of two doses of Menerba in postmenopausal women for the treatment of menopausal hot flushes (study # MF101-008), also known as "menopausal hot flashes."
More... (http://www.news-medical.net/news/20110328/Bionovo-initiates-enrollment-in-Menerba-Phase-1-clinical-trial-for-menopausal-hot-flushes.aspx)
More... (http://www.news-medical.net/news/20110328/Bionovo-initiates-enrollment-in-Menerba-Phase-1-clinical-trial-for-menopausal-hot-flushes.aspx)